By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aegerion Pharmaceuticals, Inc. 

101 Main Street
Suite 1850
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-500-7867 Fax: 908-541-1155




Company News
Aegerion (AEGR) Release: JUXTAPID (Lomitapide) Capsules Available On The Régie De l'Assurance Maladie Du Québec (RAMQ) For The Treatment Of Homozygous Familial Hypercholesterolemia (HoFH) 11/20/2015 10:50:26 AM
Aegerion (AEGR) Announces Presentation At The Leerink Rare Disease Roundtable 9/24/2015 9:48:54 AM
Aegerion (AEGR) Observes Familial Hypercholesterolemia Awareness Day 9/24/2015 9:39:08 AM
Donald K. Stern, Esq. Appointed To Aegerion (AEGR)' Board Of Directors 9/18/2015 9:26:48 AM
Aegerion (AEGR) Grants Stock Options Under Inducement Program 9/15/2015 7:54:36 AM
Ironwood (IRWD), Aegerion (AEGR), and MannKind Corporation (MNKD) Face Stiff Headwinds: Analyst 8/17/2015 7:14:37 AM
Aegerion (AEGR) Announces Second Quarter 2015 Financial Results 8/6/2015 10:54:32 AM
More Shakeups at Aegerion (AEGR) as CEO and COO Resign 7/27/2015 7:15:16 AM
Aegerion (AEGR) Grants Stock Options Under Inducement Program 7/14/2015 7:34:56 AM
Eleven Biotherapeutics (EBIO) CFO Decamps for Aegerion (AEGR) in Executive Suite Shuffle 6/25/2015 8:28:49 AM